Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development Mycenax Biotech Inc. and SPERA PHARMA Inc. have joined forces to enhance the production services of antibody-drug conjugates, streamlining development for biopharmaceutical companies.

Mycenax Biotech and SPERA PHARMA Forge Strategic Alliance for ADC Development #Taiwan #Taipei #ADC_Development #SPERA_PHARMA #Mycenax_Biotech

Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services Mycenax Biotech and SPERA PHARMA announce an impactful partnership to enhance the manufacturing of ADC products, optimizing services for biopharmaceutical companies.

Mycenax and SPERA PHARMA Team Up to Revolutionize ADC Manufacturing Services #Taiwan #Taipei #ADC_Manufacturing #SPERA_PHARMA #Mycenax_Biotech

Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services Mycenax Biotech Inc. and SPERA PHARMA have partnered to streamline biopharmaceutical manufacturing, focusing on conjugated antibody-drug services.

Mycenax and SPERA PHARMA Join Forces to Enhance Pharmaceutical Manufacturing Services #Taiwan #Taipei #Pharmaceutical_Manufacturing #SPERA_PHARMA #Mycenax_Biotech

Mycenax and SPERA PHARMA Join Forces to Enhance ADC Manufacturing Services Mycenax Biotech and SPERA PHARMA have formed a strategic alliance to optimize ADC production services, enhancing market readiness for global biopharma.

Mycenax and SPERA PHARMA Join Forces to Enhance ADC Manufacturing Services #Taiwan #Taipei #ADC_Manufacturing #Mycenax #SPERA_PHARMA